S. Korea approves Pfizer’s COVID vaccine for ages 5-11

Estimated 2.6 million Americans prescribed opioids also on various other sedatives
22 February 2022
Genomic study shows that England’s travel quarantine measures were effective—up to a limit
23 February 2022

S. Korea approves Pfizer’s COVID vaccine for ages 5-11

South Korean health officials on Wednesday approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country’s immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths.

Comments are closed.